Literature DB >> 10335456

Height, weight and gastrointestinal cancer: a follow-up study in Norway.

T E Robsahm1, S Tretli.   

Abstract

It has been suggested that components of our diet play an essential role in carcinogenesis. Anthropometric indices, such as body weight and height, have often been considered as measurements of prevailing diet and nutrition in childhood respectively. To investigate to what extent height and body weight are associated with the risk of gastrointestinal cancer, data from a Norwegian screening programme for tuberculosis were analysed. More than 1,100,000 individuals, aged 30-69 years at the time of examination, were included in the study. Body weight, expressed as Quetelet's index (QI), and height records were linked with vital status data from Statistics Norway and the Cancer Registry of Norway. The analysis shows that individuals in the first quintile of height had a lower relative risk than later quintiles for colon cancer, independent of sex and stage of disease at completion of follow-up. The association between height and rectal cancer is similar, but weaker. Men in the fifth quintile of QI have a relative risk of 1.39 for colon cancer, compared with the first quintile, and they also have a slightly elevated risk for rectal cancer. Among women, the pattern is unclear, but we observed a significant relationship between high QI and cancer of the gallbladder. Our results indicate that prevailing diet and living conditions in early life do play a role, and seem to support the hypothesis that anthropometric indices could be of importance as indirect markers for the risk of colon cancer and, to some extent, for cancer of the rectum and gallbladder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335456     DOI: 10.1097/00008469-199904000-00004

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

Review 1.  Conditions in utero and cancer risk.

Authors:  Tom Grotmol; Elisabete Weiderpass; Steinar Tretli
Journal:  Eur J Epidemiol       Date:  2006-09-13       Impact factor: 8.082

2.  Do different measures of early life socioeconomic circumstances predict adult mortality? Evidence from the British Whitehall II and French GAZEL studies.

Authors:  Silvia Stringhini; Aline Dugravot; Mika Kivimaki; Martin Shipley; Marie Zins; Marcel Goldberg; Jane E Ferrie; Archana Singh-Manoux
Journal:  J Epidemiol Community Health       Date:  2010-07-30       Impact factor: 3.710

3.  Adult-Attained Height and Colorectal Cancer Risk: A Cohort Study, Systematic Review, and Meta-Analysis.

Authors:  Elinor Zhou; Lin Wang; Celina N Santiago; Julie Nanavati; Samara Rifkin; Emma Spence; Linda M Hylind; Joell J Gills; Louis La Luna; David R Kafonek; David M Cromwell; Julia L Drewes; Cynthia L Sears; Francis M Giardiello; Gerard E Mullin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

4.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

5.  Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.

Authors:  José Díaz-Chávez; Miguel A Fonseca-Sánchez; Elena Arechaga-Ocampo; Ali Flores-Pérez; Yadira Palacios-Rodríguez; Guadalupe Domínguez-Gómez; Laurence A Marchat; Lizeth Fuentes-Mera; Guillermo Mendoza-Hernández; Patricio Gariglio; César López-Camarillo
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

6.  Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study.

Authors:  N Shimizu; C Nagata; H Shimizu; M Kametani; N Takeyama; T Ohnuma; S Matsushita
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

7.  Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men.

Authors:  A Engeland; S Tretli; T Bjørge
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.